Elan Investors OK $1B Buyback As Royalty Pharma Looms
Shareholders in Elan Corp. PLC on Friday overwhelmingly approved a $1 billion stock buyback plan as speculation swirled that investment firm Royalty Pharma LLC would beef up a takeover offer, which...To view the full article, register now.
Already a subscriber? Click here to view full article